Arch Capital Lags Industry, Trades at a Discount: Time to Hold or Exit?

Arch Capital posted an 82.5% accident-year combined ratio excluding catastrophes in Q2 2026, while pretax net investment income rose to $417 million from $405 million and investable assets reached $49.5 billion. The company repurchased $1.2 billion of stock in Q2, or $1.92 billion in the first half, and book value per share increased 2.8% to $68.04. Offsetting these positives, catastrophe losses of $201 million drove the reported combined ratio to 98.5%, while reinsurance net premiums written fell 10.4% and consolidated premiums declined 6.9%; consensus forecasts call for 2026 EPS and revenue declines of 4.1% and 5.8%, respectively.

Analysis

ACGL's relevant edge is not headline premium growth but capital allocation through a softening cycle: repurchasing stock near 1.4x book while retaining an underwriting return materially above its peer set can protect per-share book value even if top-line written premium contracts. The key distinction versus PGR and WRB is mix: ACGL's casualty and specialty lines can continue to reprice while property and peak-zone reinsurance absorb excess capacity. Third-party capital is a second-order positive only if fee income and underwriting economics remain favorable; otherwise it signals that management sees declining marginal returns on its own balance sheet.

The near-term stock catalyst is evidence that casualty rate adequacy offsets property/reinsurance runoff, alongside another material reduction in share count. Over 1-3 months, quarterly net premium retention, ex-cat accident-year combined ratio, and buyback pace matter more than consensus EPS, which has not yet moved. A sub-90% ex-cat combined ratio with continued repurchases would justify a premium to peer book multiples; conversely, a sustained premium decline combined with reserve strengthening would expose the apparent valuation discount as cyclical rather than mispriced.

Contrarian view: catastrophe volatility is likely already the market's preferred explanation for weaker results, but the more consequential risk is casualty social inflation. ACGL's specialty casualty growth raises duration of loss reserves precisely as litigation funding, medical costs, and large-verdict severity remain elevated. A benign catastrophe season may therefore create a favorable entry window, while adverse reserve development—not a single event loss—is the thesis falsifier over 6-18 months.

Key Decisions for Investors

• Initiate a 1-3 month long ACGL / short WRB pair at equal dollar exposure. ACGL offers more per-share support from capital return and a less crowded growth expectation; cover if ACGL's ex-cat combined ratio exceeds 92% for two consecutive quarters or WRB's relative performance improves by more than 10%.
• Add ACGL only after the next earnings release confirms casualty renewal pricing and quarterly buybacks remain above $750M. Target 10-15% relative upside versus insurance peers if book-value growth and repurchases support a rerating toward 1.55x book; downside is 8-12% if reserve charges emerge.
• Avoid treating the reported valuation gap versus the broad insurance group as a standalone long signal. Set an alert for adverse casualty reserve development, declining renewal rates in excess-and-surplus casualty, or a sharp fall in Treasury yields; any of these would reduce earnings power and undermine buyback accretion.
• Maintain a modest long NMIH versus ACGL only as a diversification hedge if mortgage-credit conditions remain benign: its earnings are less exposed to property-cat reinsurance pricing, but exit on rising mortgage delinquencies or a meaningful housing-price reversal.